Reuters logo
BRIEF-Ultragenyx to acquire Dimension Therapeutics
October 3, 2017 / 1:00 PM / 20 days ago

BRIEF-Ultragenyx to acquire Dimension Therapeutics

Oct 3 (Reuters) - Ultragenyx Pharmaceutical Inc:

* Ultragenyx to acquire Dimension Therapeutics

* Ultragenyx Pharmaceutical Inc - deal for ‍$6.00 per share​

* Ultragenyx Pharmaceutical Inc - deal for ‍approximately $151 million in cash​

* Ultragenyx Pharmaceutical Inc - ‍transaction is structured as a tender offer and will be funded through ultragenyx’s existing cash resources​

* Ultragenyx Pharmaceutical Inc - ‍ultragenyx will pay regenxbio a termination fee pursuant to regenxbio merger agreement, on behalf of dimension​

* Ultragenyx Pharmaceutical Inc - tender offer is not subject to a financing condition Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below